dc.contributor.author | Israel, K. Njovu | |
dc.contributor.author | Benson, Musinguzi | |
dc.contributor.author | James, Mwesigye | |
dc.contributor.author | Kennedy, Kassaza | |
dc.contributor.author | Joseph, Turigurwa | |
dc.contributor.author | Edwin, Nuwagira | |
dc.contributor.author | Joel, Bazira | |
dc.contributor.author | Taseera, Kabanda | |
dc.contributor.author | Moses, Mpeirwe | |
dc.contributor.author | Lucas, Ampaire | |
dc.contributor.author | Andrew, Mutekanga | |
dc.contributor.author | James, Kiguli | |
dc.contributor.author | Beatrice, Achan | |
dc.contributor.author | Herbert, Itabangi | |
dc.date.accessioned | 2024-06-24T06:04:27Z | |
dc.date.available | 2024-06-24T06:04:27Z | |
dc.date.issued | 2021 | |
dc.identifier.citation | Njovu, I.K., Musinguzi, B., Mwesigye, J., Kassaza, K., Turigurwa, J., Nuwagira, E., Bazira, J., Kabanda, T., Mpeirwe, M., Ampaire, L. and Mutekanga, A., 2021. Status of pulmonary fungal pathogens among individuals with clinical features of pulmonary tuberculosis at Mbarara University Teaching Hospital in Southwestern Uganda. Therapeutic advances in infectious disease, 8, p.20499361211042477. | en_US |
dc.identifier.issn | https://journals.sagepub.com/doi/full/10.1177/20499361211042477 | |
dc.identifier.uri | http://hdl.handle.net/10570/13288 | |
dc.description.abstract | Background: Pulmonary mycoses are important diseases of the respiratory tract caused by
pulmonary fungal pathogens. These pathogens are responsible for significant morbidity and
mortality rates worldwide; however, less attention has been paid to them. In this study we
determined the prevalence of pulmonary fungal pathogens among individuals with clinical
features of pulmonary tuberculosis at Mbarara Regional Referral Hospital.
Method: This was a hospital based cross sectional survey. Sputum samples were collected
from each study participant. For each sample, the following tests were performed: Sabouraud
dextrose agar for fungal culture, GeneXpert for Mycobacteria tuberculosis (MTB) and potassium
hydroxide for fungal screening. Filamentous fungal growth and yeasts were further examined
with lactophenol cotton blue staining and germ tube respectively.
Results: Out of 113 study participants, 80 (70.7%) had pulmonary fungal pathogens whilst
those with pulmonary tuberculosis numbered five (4.4%). Candida albicans [21 (22.58%)] and
Aspergillus species [16 (17.20%)] were the pathogens most identified among others. Two
(1.7%) TB GeneXpert positive participants had fungal pathogens isolated from their sputum
samples. We established a prevalence of 57 (71.3%) for pulmonary fungal pathogen (PFP)
isolates, three (60.0%) for MTB in HIV positive patients and 18 (22.5%) for PFP, and zero (0.0%)
for MTB in HIV negative patients. On the other hand, two (100%) HIV positive patients had both
PFP isolates and MTB.
Conclusion: Our findings highlight the diversity of neglected pulmonary fungal pathogens
whose known medical importance in causing pulmonary mycoses cannot be over emphasized.
Therefore this presents a need for routine diagnosis for pulmonary mycoses among TB
suspects and set-up of antimicrobial profile for pulmonary fungal isolates to support clinical
management of these cases. | en_US |
dc.publisher | Therapeutic advances in infectious disease | en_US |
dc.relation.ispartofseries | ;1-11 | |
dc.subject | pulmonary fungal infections, pulmonary fungal pathogens, pulmonary mycoses, pulmonary tuberculosis | en_US |
dc.title | Status of pulmonary fungal pathogens among individuals with clinical features of pulmonary tuberculosis at Mbarara University Teaching Hospital in Southwestern Uganda | en_US |
dc.type | Article | en_US |